Summary: Gilead Sciences, Inc. and Kite, a Gilead Company, are set to present 18 abstracts during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showcasing their commitment to developing innovative cancer treatments across various tumor types. This includes data on Trodelvy in Non-Small Cell Lung Cancer, Progress in Gastrointestinal Pipeline, and New Data on CAR T-cell Therapies like Yescarta.
Full articleSummary: NextEra Energy's outlook was adjusted by BMO Capital Markets, increasing the price target to $78.00 and maintaining an Outperform rating due to executive team changes. The new CFO appointment from Goldman Sachs indicates positive growth expectations.
Full articleSummary: NextEra Energy (NEE) is a focus for income investors due to its consistent dividend payouts and growth. The company has a dividend yield of 2.48% and has been increasing its dividend annually. NEE is expected to see earnings growth of 7.59% in 2023.
Full articleSummary: Colgate-Palmolive Company (CL) experienced top and bottom-line improvements in fourth-quarter 2020 due to strong demand for its products during the COVID-19 pandemic and solid online performance. The company's commitment to pricing efforts, expansion in e-commerce business, and strategic acquisitions are contributing to organic sales growth. Management predicts net sales growth of 4-7% and gross margin expansion for 2021. Despite some headwinds like elevated expenses, the stock continues to show optimism.
Full articleSummary: PayPal Holdings, Inc. announced the appointment of Steve Winoker as Chief Investor Relations Officer, effective May 15, 2024. Winoker brings a wealth of experience in investor relations from his previous positions at GE and UBS.
Full articleSummary: Gilead Sciences, Inc. and Kite, a Gilead Company, will present 18 abstracts during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showcasing data on Trodelvy in non-small cell lung cancer (NSCLC), updated results from Phase 2 EDGE-Gastric study of domvanalimab plus zimberelimab, and pilot study results of Yescarta in primary and secondary central nervous system lymphomas.
Full articleSummary: Apollon Wealth Management LLC increased its holdings in Colgate-Palmolive stock by 95.6% in the fourth quarter, with several other hedge funds also adjusting their positions. Insiders at Colgate-Palmolive have been actively buying and selling shares recently. Wall Street analysts have mostly positive ratings for the company, with an average target price of $91.44.
Full articleSummary: FAA investigates Boeing after reports of falsified inspection records at a South Carolina plant. Boeing taking corrective action and addressing required tests to ensure safety on certain 787 Dreamliner airplanes.
Full articleSummary: Alimera Sciences, Inc. announces the presentation of scientific data related to YUTIQ at upcoming ophthalmic congresses, showcasing safety and effectiveness outcomes of the 0.18 mg Fluocinolone Acetonide Intravitreal Implant in patients with chronic non-infectious uveitis affecting the posterior segment.
Full articleSummary: The IBD Stock Screener highlights stocks that mutual funds are buying including Amazon.com, Broadcom and Eli Lilly, with Amazon stock climbing back to a recent high.
Full articleSummary: Alphabet Inc. (GOOGL) continues to benefit from strength in cloud business and AI techniques, while facing challenges in its advertisement business. Tesla, Inc. (TSLA) is expected to deliver outsized returns in the long run with the introduction of new models. Amgen Inc. (AMGN) beat Q4 estimates but faces challenges from increasing competition for its legacy products.
Full articleSummary: Nvidia's upcoming RTX graphics cards lineup might have a change in its release order, with RTX 5080 potentially being the first to debut, contrary to expectations. The possibility of a 'paper launch' for RTX 5080 is also discussed.
Full articleSummary: Victory Capital Management Inc. decreased its position in shares of The Charles Schwab Co. by 1.7% during the fourth quarter. Insider activities include selling of shares by Chairman Charles R. Schwab and insider Jonathan M. Craig. Analysts have offered mixed ratings for SCHW stock.
Full articleSummary: ConocoPhillips saw a decline in earnings for the first quarter of 2024 compared to the same period last year and the previous quarter due to weaker prices offsetting higher oil and gas production. The company distributed $2.2 billion to shareholders through buybacks and dividends, maintained dividend rates, and highlighted continued ramp-up of international projects.
Full articleSummary: Ford Motor Company's total return has lagged the broader S&P 500 in the last years, with its market cap briefly exceeding $100 billion in early 2022 before dropping to $50 billion by May 2022. The company is seeing improving financial results and revenue growth, but challenges remain, particularly in the EV segment.
Full articleSummary: Great Valley Advisor Group Inc. reduced its stake in Danaher Co. by 9.1% in the 4th quarter. Other hedge funds also made changes to their positions in the company. Danaher recently increased its dividend and announced its quarterly earnings results, beating the consensus estimate. Analysts set new price targets for Danaher stock.
Full articleSummary: Philip Morris International Inc. presents at Jefferies Virtual Reduced Risk Seminar focusing on smoke-free products and nicotine, showcasing their ambition to expand into wellness and healthcare areas through their Vectura Fertin Pharma business. PMI is actively delivering a smoke-free future and investing in innovative smoke-free products.
Full articleSummary: Discounts on Asus RTX 4070 Super Dual EVO variant with cashback offer available through Asus' 'Rate My Gear' promo, providing good performance for 1440p gaming.
Full articleSummary: RTX insiders, including the Director and President of Pratt & Whitney, have sold substantial amounts of stock over the past year, raising concerns among shareholders. Despite high insider ownership, lack of insider buying and overall selling activities have left investors cautious about the stock.
Full articleSummary: Kestra Private Wealth Services LLC increased its stake in The Bank of New York Mellon Co. by 3.1% during the fourth quarter, holding 8,059 shares valued at $419,000. A number of other institutional investors and hedge funds also made changes to their positions in BK. 85.31% of the stock is owned by hedge funds and other institutional investors. Several equities research analysts have recently given a 'buy' rating to BK shares. Bank of New York Mellon stock is trading up 0.8%. The company last issued its earnings results on Tuesday, April 16th, beating the consensus estimate and reporting $1.29 earnings per share for the quarter.
Full articleSummary: GE Aerospace researchers have successfully integrated generative AI with computer vision to demonstrate AI with child-like learning capabilities funded through DARPA's ECOLE program, enabling AI-agents to perform future DoD mission-critical analytical tasks, showcasing a new form of continuous learning where the system can analyze its mistakes and improve its performance.
Full articleSummary: DA Davidson research analysts issued their Q2 2024 earnings per share estimate for Booking Holdings Inc., forecasting $38.69 for the quarter. They also provided EPS estimates for FY2024 and FY2025. Booking exceeded the consensus estimate for Q2 with $20.39 EPS, showcasing a positive revenue increase compared to the same quarter last year.
Full articleSummary: Savant Capital LLC bought a new stake in shares of Schwab U.S. REIT ETF in the fourth quarter. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Schwab U.S. REIT ETF has a market cap of $6.10 billion.
Full articleSummary: Berkshire Hathaway's annual shareholder meeting attracted around 40,000 investors to listen to Warren Buffett speak about the stock market and the U.S. economy. Despite Buffett's long-term investing ethos, the company has been on a net-selling spree of equities, totaling $56.09 billion over 18 months, signaling potential trouble in the market. However, Buffett's history of patience during economic turbulence and the company's large cash pile suggest they are waiting for better investment opportunities.
Full articleSummary: The FDA has initiated Project Optimus to promote less toxic and more effective cancer drugs, particularly focusing on optimizing dosages. Amgen's drug sotorasib, touted as innovative in the treatment of lung cancer, faced scrutiny for its high dosage despite severe side effects experienced by patients. Some argue that a lower dosage could be more effective and reduce costs.
Full articleSummary: Thermo Fisher Scientific Inc. (NYSE:TMO) has $35.4 billion of debt, but its interest coverage suggests it can handle its debt well. The company's net debt to EBITDA is 2.6 times, indicating a reasonable amount of leverage. Thermo Fisher Scientific has a strong free cash flow of 81% of its EBIT, positioning it well to pay down debt if needed.
Full articleSummary: NextEra Energy's return on capital employed (ROCE) is 5.8%, which is higher than the industry average of 4.7%. However, despite increasing the capital employed by 70% in the last five years, the returns have remained stable, indicating low return on capital. The stock has gained 64% over the last five years, but the lack of significant increase in returns on capital raises concerns for future growth opportunities.
Full article